Ingredient
Adapalene
Adapalene is flagged for pregnancy, breastfeeding and trying to conceive. The concern behind the strongest flag is known teratogen and fetal development.
- Differin
Verdict by profile
Truva checks every ingredient against six profiles. Jump to any of them for the full assessment.
- Strongest verdict
- Not Recommended
- Its verdict for pregnancy, the profile this one is worst in
- Profiles flagged
- 3 of 6
- Counting avoid, high risk and medium risk
- Irritancy
- 4 of 5
- Higher means more likely to sting or redden
Adapalene and pregnancy
Not Recommended
- Known teratogen
- Fetal development
Adapalene is a third-generation synthetic retinoid used for acne treatment and anti-aging. While topical retinoids like adapalene have much lower systemic absorption compared to oral retinoids (such as isotretinoin), they are still vitamin A derivatives and share a similar mechanism of action at the cellular level. According to ACOG, all retinoids should be avoided during pregnancy due to the known teratogenicity of oral retinoids, which can cause severe birth defects including craniofacial, cardiac, and CNS abnormalities. While studies show that systemic absorption of topical adapalene is minimal (blood levels are extremely low), and there is no definitive evidence that topical retinoids cause birth defects in humans, ACOG and most obstetricians recommend avoiding all forms of vitamin A derivatives during pregnancy as a precautionary measure. The FDA classifies adapalene as Pregnancy Category C based on animal studies showing adverse fetal effects. The American Academy of Dermatology (AAD) and ACOG both recommend discontinuing all topical retinoids, including adapalene, as soon as pregnancy is confirmed or when attempting to conceive. This conservative approach is based on the known teratogenicity of the retinoid class and the importance of avoiding any potential risk during fetal development, even if that risk is theoretical for topical formulations.
Adapalene and breastfeeding
Not Recommended
- Passes into breast milk
- Infant exposure
Adapalene is a topical retinoid with very low systemic absorption: pharmacokinetic studies show minimal detection in blood even with widespread application. However, as a fat-soluble vitamin A derivative, there is theoretical potential for any absorbed adapalene to transfer into breast milk. While specific data on adapalene excretion into breast milk is limited, the AAD notes that most dermatologists recommend postponing use of retinoids until after weaning due to theoretical concerns about infant vitamin A exposure. Excessive vitamin A can be toxic to infants, and while the risk from topical maternal use appears low, it cannot be definitively ruled out. The conservative approach is based on the retinoid class effects rather than specific data for adapalene. Some dermatologists consider the risk from topical adapalene minimal given the extremely low systemic absorption and may approve limited use for severe acne when applied away from breast areas. However, the general medical consensus is to avoid retinoids during breastfeeding when possible and use alternative acne treatments like azelaic acid or topical antibiotics that have better established safety profiles during lactation.
Adapalene and postpartum
Safe to Use
- Irritant
For postpartum women who are not breastfeeding, adapalene is safe to use and can be highly beneficial for treating pregnancy-related acne, melasma, and textural changes. It helps normalize skin cell turnover and can improve both acne and signs of aging that may have developed or worsened during pregnancy. The main concerns are the typical side effects: irritation, dryness, and increased sun sensitivity. Postpartum skin may be more sensitive due to hormonal fluctuations, so starting with a lower frequency (every 2-3 nights) and gradually increasing as tolerated is advisable. Always use sunscreen during the day as retinoids increase photosensitivity.
Adapalene and trying to conceive
Not Recommended
- Known teratogen
- Builds up in tissue
Women trying to conceive should discontinue adapalene before attempting pregnancy. While topical adapalene has minimal systemic absorption and is unlikely to accumulate in the body significantly, the standard medical recommendation is to stop all retinoids at least one month before trying to conceive as a precautionary measure. This conservative approach is based on the known teratogenicity of oral retinoids and the desire to eliminate any theoretical risk before pregnancy occurs. ACOG recommends discontinuing topical retinoids when planning pregnancy, even though the actual risk from topical use appears much lower than from oral forms. The timing allows for any residual compound to clear before conception.
Adapalene and PCOS
Safe to Use
Adapalene is particularly beneficial for women with PCOS who often struggle with acne related to elevated androgen levels. It works by preventing clogged pores, reducing inflammation, and normalizing skin cell turnover: directly addressing the mechanisms behind hormonal acne. Studies specifically examining adapalene use in PCOS-related acne show significant improvement in inflammatory lesions and comedones. It is often considered a first-line treatment for persistent acne in PCOS, sometimes combined with other therapies like spironolactone or hormonal contraceptives. Adapalene has no effect on hormone levels themselves and does not interfere with PCOS treatments. The AAD recommends topical retinoids like adapalene as part of comprehensive acne management for PCOS. It is well-tolerated by most users once the initial adjustment period passes, and it addresses both active acne and post-inflammatory hyperpigmentation that frequently accompanies PCOS-related breakouts.
Adapalene and general use
Safe to Use
- Irritant
- Increases sun sensitivity
Adapalene is a highly effective ingredient for both acne treatment and anti-aging benefits. It is considered more stable and less irritating than other retinoids like tretinoin, while providing comparable results. Studies show it reduces fine lines, improves skin texture, fades dark spots, and prevents acne formation. The primary concerns are tolerability-related rather than safety-related. Initial use commonly causes redness, dryness, peeling, and increased sensitivity, known as the 'retinization' period. These effects typically diminish within 2-4 weeks. Adapalene significantly increases photosensitivity, making diligent sun protection essential. It should not be used in combination with other potentially irritating ingredients initially. The FDA has approved adapalene for over-the-counter sale at 0.1% concentration, reflecting its established safety profile for the general adult population. It has been extensively studied and used for over 25 years. Long-term use is safe and often necessary to maintain benefits. The AAD considers it a gold-standard treatment for acne and a well-proven anti-aging ingredient.
Everything else flagged for the same profiles
Related ingredients
Ingredients suggested in place of Adapalene, each one with its own page here.
Ingredients that raise the same concerns.
Where this came from
Truva summarises published guidance from bodies including ACOG, the FDA, the EU SCCS and the Cosmetic Ingredient Review. It has no access to your medical history and it is not a substitute for your doctor, dermatologist or midwife. These assessments have not been reviewed by a clinician, and nothing here is a diagnosis or a prescription. If you are pregnant, breastfeeding or being treated for PCOS, take the ingredient list to the person looking after you.
Assessment last pulled from the ingredient database on .
One ingredient is the easy case.
A label has thirty of them. Truva reads the whole list at once and answers for the profile you set: pregnancy, breastfeeding, postpartum, trying to conceive, PCOS, or general use.
Download on theApp Store